|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,455.00 JPY | +2.09% |
|
-6.18% | -18.73% |
Company Valuation: COSMOS Pharmaceutical Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 603,094 | 483,107 | 525,081 | 502,890 | 700,001 | 511,606 | - | - |
| Change | - | -19.9% | 8.69% | -4.23% | 39.2% | -26.91% | - | - |
| Enterprise Value (EV) 1 | 553,560 | 450,132 | 497,354 | 477,918 | 692,920 | 491,326 | 486,005 | 483,277 |
| Change | - | -18.68% | 10.49% | -3.91% | 44.99% | -29.09% | -1.08% | -0.56% |
| P/E | 22.2x | 20.9x | 22.1x | 20.6x | 22.6x | 14.9x | 16.4x | 15.1x |
| PBR | 3.54x | 2.54x | 2.49x | 2.17x | 2.72x | 1.68x | 1.66x | 1.52x |
| PEG | - | -1.4x | 7.98x | 7.61x | 0.8x | 4.32x | -8.69x | 1.81x |
| Capitalization / Revenue | 0.83x | 0.64x | 0.63x | 0.52x | 0.69x | 0.43x | 0.43x | 0.4x |
| EV / Revenue | 0.76x | 0.6x | 0.6x | 0.5x | 0.69x | 0.45x | 0.41x | 0.38x |
| EV / EBITDA | 11.8x | 10x | 10.5x | 9.29x | 11.1x | 7.4x | 6.93x | 6.46x |
| EV / EBIT | 16.7x | 15.1x | 16.5x | 15.2x | 17.1x | 11.7x | 11x | 10.4x |
| EV / FCF | 65.2x | -39.1x | 93.5x | -222x | -807x | 113x | 131x | 630x |
| FCF Yield | 1.53% | -2.56% | 1.07% | -0.45% | -0.12% | -4.85% | 0.76% | 0.16% |
| Dividend per Share 2 | 35 | 40 | 50 | 60 | 70 | 82 | 84.2 | 89.51 |
| Rate of return | 0.46% | 0.66% | 0.75% | 0.95% | 0.79% | 1.36% | 1.3% | 1.39% |
| EPS 2 | 342.9 | 292.4 | 300.5 | 308.6 | 390.9 | 404.3 | 394.5 | 427.5 |
| Distribution rate | 10.2% | 13.7% | 16.6% | 19.4% | 17.9% | 20.3% | 21.3% | 20.9% |
| Net sales 1 | 726,424 | 755,414 | 827,697 | 964,989 | 1,011,390 | 1,099,583 | 1,190,218 | 1,273,178 |
| EBITDA 1 | 46,932 | 44,906 | 47,496 | 51,425 | 62,633 | 66,929 | 70,103 | 74,852 |
| EBIT 1 | 33,147 | 29,796 | 30,128 | 31,501 | 40,404 | 42,353 | 44,041 | 46,529 |
| Net income 1 | 27,156 | 23,155 | 23,797 | 24,454 | 30,978 | 32,046 | 31,371 | 33,890 |
| Net Debt 1 | -49,534 | -32,975 | -27,727 | -24,972 | -7,081 | -20,280 | -25,601 | -28,329 |
| Reference price 2 | 7,615.00 | 6,100.00 | 6,630.00 | 6,345.00 | 8,832.00 | 6,455.00 | 6,455.00 | 6,455.00 |
| Nbr of stocks (in thousands) | 79,198 | 79,198 | 79,198 | 79,258 | 79,257 | 79,257 | - | - |
| Announcement Date | 12/7/21 | 11/7/22 | 10/7/23 | 12/7/24 | 11/7/25 | 13/7/26 | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.73x | 0.44x | 7.24x | 1.2% | 3.16B | ||
| 23.46x | 0.4x | 6.17x | 2.04% | 6.84B | ||
| 15.36x | 0.43x | 6.35x | 1.37% | 3.15B | ||
| 12.77x | 0.45x | 5.58x | 3.75% | 2.72B | ||
| 20.96x | 0.79x | 11.12x | 1.44% | 2.38B | ||
| 14.55x | 0.43x | 4.1x | 3.48% | 1.39B | ||
| 16.61x | 0.48x | 6.59x | 4.29% | 346M | ||
| Average | 17.06x | 0.49x | 6.74x | 2.51% | 2.86B | |
| Weighted average by Cap. | 18.47x | 0.47x | 6.74x | 2.1% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3349 Stock
- Valuation COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
















